Does Tween 20 Affect Monoclonal Antibody Separation?

Importance of the Topic

The nonionic surfactant Tween 20 is commonly employed in monoclonal antibody sample preparation for its ability to stabilize proteins, solubilize membranes, and prevent nonspecific binding. Concerns have been raised that residual Tween 20 in samples or eluents could interact with size exclusion chromatography (SEC) column matrices, potentially compromising separation performance and data integrity.

Objectives and Study Overview

This application study aimed to determine whether 0.1% Tween 20 present in either the sample or the eluent affects SEC analysis of IgG using an Agilent Bio SEC–3 column. Both single-injection and multiple-injection protocols were executed to evaluate retention behavior, resolution, and aggregate/dimer/monomer distribution.

Methodology and Instrumentation

• Column: Agilent Bio SEC–3, 300 Å, 7.8 × 300 mm, 3 µm particle size.
• Eluent: 150 mM sodium phosphate buffer, pH 7, with or without 0.1% Tween 20.
• Flow Rate: 1.0 mL/min.
• Detectors: UV at 220 nm for protein peaks; refractive index for surfactant detection.
• System: Agilent 1260 Infinity Bio-inert Quaternary LC System.

Key Results and Discussion

• No coelution was observed: tween 20 eluted at ~11.3 min while IgG monomer and dimer eluted at ~7.6 min and ~6.7 min, respectively.
• Single injections of IgG with or without 0.1% Tween 20 yielded very similar aggregate, dimer, and monomer area ratios (around 6–9% aggregates, 16–18% dimers, 73–78% monomer) and consistent resolution factors.
• After multiple injections of Tween 20 and IgG samples, the column maintained stable performance, with negligible shifts in retention times, resolution, and ratio metrics up to 50 injections.
• A post-study ethanol cleaning (20% ethanol flush) restored the column to its original separation characteristics when tested with a Bio-Rad protein standard, demonstrating no lasting adverse effects from Tween 20 exposure.

Benefits and Practical Applications

The findings confirm that Agilent Bio SEC–3 columns can robustly separate monoclonal antibodies in the presence of low levels of Tween 20 without the need for detergent removal steps. This capability simplifies workflows in biotherapeutic characterization and quality control, supporting high-throughput analyses with minimal sample preparation modifications.

Future Trends and Opportunities

Further exploration may involve extending this approach to other nonionic detergents or higher surfactant concentrations, integrating SEC with mass spectrometry for deeper structural insights, and developing automated platforms for large-scale biopharmaceutical screening. Advances in column chemistries may also enhance resolution of complex protein assemblies in detergent-rich environments.

Conclusion

This study demonstrates that 0.1% Tween 20 in sample or eluent does not compromise the performance of Agilent Bio SEC–3 columns for monoclonal antibody separation. The columns sustain consistent retention, resolution, and peak area distribution during extensive use and after cleaning, endorsing their reliability for routine SEC analysis in biotherapeutic research and QC settings.